We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Crystal-Growing Process Speeds Genetic Research

By Biotechdaily staff writers
Posted on 18 Jul 2002
Scientists have developed a new process that reduces the time needed to find the structure of a human protein from as much as a year to as little as one month. More...
The results of their research were reported in the July 2002 issue of Biological Crystallography.

Developed by Dr. Jose Gavira and Dr. JuanMa Garcia-Ruiz at the University of Granada (Spain), the new process uses diffusion, working on an almost microscopic scale. Tiny capillary tubes filled with protein solutions are dipped into vials full of various solvents, heavy metals, and reagents. Where the solutions meet, they diffuse one into the other, like cream into coffee. As the solutions mix through the tube, they create an almost infinite range of relative concentrations to one another. When the solutions reach the mixture that is just right, a crystal will start to grow.

"It kind of self-selects the optimal conditions,” said Dr. Joseph Ng, an assistant biology professor at the University of Alabama (Huntsville, USA) and one of the researchers on the project. "It goes pretty quickly. Instead of doing hundreds of tests with hundreds of samples, we do it all in one tube.”

Until now, preparing crystals for testing has been a laborious and time-consuming process. A lot of the problems in determining structure arose from the damage caused by handling the crystals. With the new process, everything is done with the crystal inside the tube. This means there is no handling, and thus no damage. Moreover, it can be done in a few weeks instead of several months.




Related Links:
Univ. of Alabama
Univ. of Granada

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
High-Density Lipoprotein Containing Cholesterol Assay
HDL-c direct FS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.